AUTL SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 11, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 27, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 12, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 12, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 8, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Autolus Therapeutics Reports Q2 2026 Financial Results and Increased Revenue Guidance

Aug 11, 2026

8-K

Autolus Therapeutics Reports Preliminary Q2 2026 Revenue and Secures $250 Million Credit Facility

Aug 3, 2026

8-K

Autolus Therapeutics Enters $250 Million Senior Secured Notes Facility with Perceptive

Aug 3, 2026

8-K

Autolus Therapeutics plc Announces Results of 2026 Annual General Meeting

Jun 29, 2026

8-K

Autolus Therapeutics 2025 Annual Report and Commercial Progress Update

Jun 9, 2026

8-K

Autolus Therapeutics Reports Q1 2026 Financial Results and Operational Updates

May 14, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Sep 22, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 54,584,250

Jan 26, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 54,584,250

Jan 12, 2026

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 54,584,250 | Warrants amount: 3,265,306

Dec 2, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 54,584,250 | Warrants amount: 3,265,306

Nov 12, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 54,584,250 | Warrants amount: 3,265,306 |

Aug 12, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-3

SHARE RESALE REGISTRATION

Sep 11, 2026

S-3

April 2026 SHELF

Apr 10, 2026

S-3

SHARE RESALE REGISTRATION

Apr 10, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Nov 18, 2025

S-1

SHARE RESALE REGISTRATION

May 8, 2025

POS AM

Form POS AM - Post-Effective amendments for registration statement

Mar 20, 2025

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

S-3

Form S-3 - Registration statement under Securities Act of 1933

Sep 11, 2026

Piccina Cintia (Reporting)

Sep 3, 2026

144

Form 144 - Report of proposed sale of securities

Sep 2, 2026

SCHEDULE 13D/A

PPF Group a.s. (Filed by)

Aug 28, 2026

SCHEDULE 13G/A

ARMISTICE CAPITAL, LLC (Filed by)

Aug 14, 2026

YOUNG WILLIAM D (Reporting)

Jul 1, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Sep 23, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

May 6, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

May 6, 2026

CORRESP

Form CORRESP - Correspondence

May 1, 2026

CORRESP

Form CORRESP - Correspondence

May 1, 2026

LETTER

Form UPLOAD - SEC-generated letter

Apr 15, 2026

Autolus Therapeutics plc AUTL · SEC Filings